Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $1.7 million.

  • Pharma-Bio Serv's Total Current Liabilities fell 786.19% to $1.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.7 million, marking a year-over-year decrease of 786.19%. This contributed to the annual value of $1.7 million for FY2025, which is 786.19% down from last year.
  • According to the latest figures from Q4 2025, Pharma-Bio Serv's Total Current Liabilities is $1.7 million, which was down 786.19% from $1.7 million recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Total Current Liabilities ranged from a high of $5.5 million in Q1 2021 and a low of $1.7 million during Q3 2025
  • In the last 5 years, Pharma-Bio Serv's Total Current Liabilities had a median value of $2.2 million in 2022 and averaged $2.5 million.
  • In the last 5 years, Pharma-Bio Serv's Total Current Liabilities soared by 18439.62% in 2021 and then crashed by 5805.35% in 2022.
  • Over the past 5 years, Pharma-Bio Serv's Total Current Liabilities (Quarter) stood at $2.7 million in 2021, then fell by 21.03% to $2.1 million in 2022, then grew by 2.18% to $2.2 million in 2023, then fell by 12.37% to $1.9 million in 2024, then decreased by 7.86% to $1.7 million in 2025.
  • Its Total Current Liabilities was $1.7 million in Q4 2025, compared to $1.7 million in Q3 2025 and $1.8 million in Q2 2025.